Mild Hemophilia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mild Hemophilia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Mild Hemophilia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Currently, few recommendations exist for patients with mild hemophilia, who represent approximately 60% of the hemophilia population. This study aims to provide…
This is a multicenter, open-label, single-arm study designed to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of emicizumab in participa…